BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12861972)

  • 1. Antiviral Research--16th International Conference: 27 April-1 May 2003, Savannah, GA, USA.
    Vere Hodge A
    IDrugs; 2003 Jun; 6(6):512-4. PubMed ID: 12861972
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanisms of antiviral resistance among the herpesvirus group].
    Reina J
    Enferm Infecc Microbiol Clin; 1997; 15(6):329-34. PubMed ID: 9376408
    [No Abstract]   [Full Text] [Related]  

  • 3. Ganciclovir resistance: a matter of time and titre.
    Drew WL
    Lancet; 2000 Aug; 356(9230):609-10. PubMed ID: 10968428
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of multidrug-resistant viruses in the immunocompromised host.
    Sellar RS; Peggs KS
    Br J Haematol; 2012 Mar; 156(5):559-72. PubMed ID: 22188225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective anti-herpesvirus agents.
    De Clercq E
    Antivir Chem Chemother; 2013 Jan; 23(3):93-101. PubMed ID: 23343513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs for non-HIV viral infections.
    Treat Guidel Med Lett; 2007 Jul; 5(59):59-70. PubMed ID: 17565338
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antivirals for herpesviruses and cytomegalovirus].
    Minematsu T
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():396-400. PubMed ID: 17455652
    [No Abstract]   [Full Text] [Related]  

  • 8. Herpesviridae and novel inhibitors.
    Siakallis G; Spandidos DA; Sourvinos G
    Antivir Ther; 2009; 14(8):1051-64. PubMed ID: 20032535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. n-docosanol: broad spectrum anti-viral activity against lipid-enveloped viruses.
    Katz DH; Marcelletti JF; Pope LE; Khalil MH; Katz LR; McFadden R
    Ann N Y Acad Sci; 1994 Jun; 724():472-88. PubMed ID: 8030975
    [No Abstract]   [Full Text] [Related]  

  • 10. Susceptibility of herpesviruses to three nucleoside analogues and their combinations and enhancement of the antiviral effect of acid pH.
    Fiala M; Chow AW; Miyasaki K; Guze LB
    J Infect Dis; 1974 Jan; 129(1):82-5. PubMed ID: 4358268
    [No Abstract]   [Full Text] [Related]  

  • 11. European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Reusser P; Cordonnier C; Einsele H; Engelhard D; Link D; Locasciulli A; Ljungman P
    Bone Marrow Transplant; 1996 May; 17(5):813-7. PubMed ID: 8733703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Viruses and antiviral drug resistance].
    Hovi T; Järvinen A; Pyhälä R; Ristola M; Salminen M
    Duodecim; 2002; 118(9):911-8. PubMed ID: 12238169
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy of herpes virus infections in children.
    Whitley RJ
    Adv Exp Med Biol; 2008; 609():216-32. PubMed ID: 18193668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral drugs.
    Balfour HH
    N Engl J Med; 1999 Apr; 340(16):1255-68. PubMed ID: 10210711
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytomegalovirus antiviral drug resistance: future prospects for prevention, detection and management.
    Hanson KE; Swaminathan S
    Future Microbiol; 2015; 10(10):1545-8. PubMed ID: 26437628
    [No Abstract]   [Full Text] [Related]  

  • 16. [Development in and role of antiviral agents].
    Lange JM; van der Noordaa J
    Ned Tijdschr Geneeskd; 1992 May; 136(20):958-64. PubMed ID: 1317510
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiviral Research--16th International Congress: HBV and HCV. 27 April-1 May 2003, Savannah, GA, USA.
    Smee D
    IDrugs; 2003 Jun; 6(6):518-21. PubMed ID: 12861975
    [No Abstract]   [Full Text] [Related]  

  • 18. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.
    Neyts J; De Clercq E
    Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral drugs in the immunocompetent host: part I. Treatment of hepatitis, cytomegalovirus, and herpes infections.
    Colgan R; Michocki R; Greisman L; Moore TA
    Am Fam Physician; 2003 Feb; 67(4):757-62, 675. PubMed ID: 12613729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo.
    Kaptein SJ; Efferth T; Leis M; Rechter S; Auerochs S; Kalmer M; Bruggeman CA; Vink C; Stamminger T; Marschall M
    Antiviral Res; 2006 Feb; 69(2):60-9. PubMed ID: 16325931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.